Needham Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Needham Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS)
September 13, 2024 5:13 AM EDT
Truist Securities analyst Kaila Krum raised the price target on OrthoPediatrics Corp. (NASDAQ: KIDS) to $34.00 (from $30.00) while maintaining a Hold rating.
The analyst comments "KIDS' I-Day emphasized a diversifying set of growth drivers---new prod launches, addt'l target markets, and a scaling sales... More
September 12, 2024 7:05 AM EDT
OrthoPediatrics Corp. (OrthoPediatrics) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the launch of its Enabling Technologies division. The Enabling Technologies division will leverage the company's core mission of addressing unmet pediatric needs in orthopedics and apply this focus to new areas within digital health and advanced technology. Led by industry veteran, Kevin Unger, this new division is set to differentiate OrthoPediatrics' core business, generate sustainable revenue growth, and access new markets and specialties beyond... More
